D
Denali Therapeutics Inc. DNLI
$15.15 $0.261.75%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -7.05% -8.25% 2.73% 14.79% -20.25%
Total Depreciation and Amortization -332.75% 16.84% -10.18% -0.69% -1.80%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 66.94% 10.05% 666.28% -85.69% -9.80%
Change in Net Operating Assets -65.22% 471.99% 48.39% -370.30% 232.72%
Cash from Operations -41.56% 35.17% 19.71% -15.17% -12.93%
Capital Expenditure -31.10% 18.85% -122.60% 3.80% -8.08%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 81.77% -5.63% 122.91% -699.13% -26.89%
Cash from Investing 83.87% -4.99% 121.75% -720.40% -27.61%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 65.34% -- -- -- --
Issuance of Common Stock -30.00% -12.14% -98.65% 10,532.84% 88.80%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 100.00% -- -- -- --
Cash from Financing 77.54% -374.70% -98.65% 10,532.84% 88.80%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 428.45% 13.13% 121.20% -218.26% -230.35%
Weiss Ratings